200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 109944-15-2
109944-15-2 | Imidazo[1,2-a]pyridine-2,3-dione,hexahydro-6,7,8-trihydroxy-5-(hydroxymethyl)-, (5R,6R,7S,8R,8aS)-
CAS No: 109944-15-2 Catalog No: AG01CC21 MDL No:MFCD00270017
Product Description
Catalog Number:
AG01CC21
Chemical Name:
Imidazo[1,2-a]pyridine-2,3-dione,hexahydro-6,7,8-trihydroxy-5-(hydroxymethyl)-, (5R,6R,7S,8R,8aS)-
CAS Number:
109944-15-2
Molecular Formula:
C8H12N2O6
Molecular Weight:
232.1907
MDL Number:
MFCD00270017
IUPAC Name:
(5R,6R,7S,8R,8aS)-6,7,8-trihydroxy-5-(hydroxymethyl)-1,5,6,7,8,8a-hexahydroimidazo[1,2-a]pyridine-2,3-dione
InChI:
InChI=1S/C8H12N2O6/c11-1-2-3(12)4(13)5(14)6-9-7(15)8(16)10(2)6/h2-6,11-14H,1H2,(H,9,15)/t2-,3-,4+,5+,6+/m1/s1
InChI Key:
OIURYJWYVIAOCW-PQMKYFCFSA-N
SMILES:
OC[C@@H]1[C@@H](O)[C@H](O)[C@@H]([C@@H]2N1C(=O)C(=O)N2)O
UNII:
0NI8960271
Properties
Complexity:
335
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
5
Defined Bond Stereocenter Count:
0
Exact Mass:
232.07g/mol
Formal Charge:
0
Heavy Atom Count:
16
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
5
Isotope Atom Count:
0
Molecular Weight:
232.192g/mol
Monoisotopic Mass:
232.07g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
130A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-2.8
Literature
| Title | Journal |
|---|---|
| Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. | Nature structural & molecular biology 20130701 |
| Synthesis of kifunensine thioanalogs and their inhibitory activities against HIV-RT and α-mannosidase. | Carbohydrate research 20130110 |
| TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor. | The Biochemical journal 20120801 |
| Glycoforms of UT-A3 urea transporter with poly-N-acetyllactosamine glycosylation have enhanced transport activity. | American journal of physiology. Renal physiology 20120715 |
| Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans. | mAbs 20120701 |
| Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications. | Human mutation 20120201 |
| Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases. | The Journal of biological chemistry 20111216 |
| Role of the endoplasmic reticulum-associated degradation (ERAD) pathway in degradation of hepatitis C virus envelope proteins and production of virus particles. | The Journal of biological chemistry 20111028 |
| Use of the α-mannosidase I inhibitor kifunensine allows the crystallization of apo CTLA-4 homodimer produced in long-term cultures of Chinese hamster ovary cells. | Acta crystallographica. Section F, Structural biology and crystallization communications 20110701 |
| Differential expression and function of α-mannosidase I in stimulated naive and memory CD4+ T cells. | Journal of immunotherapy (Hagerstown, Md. : 1997) 20110601 |
| Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF-beta. | Journal of cellular physiology 20100401 |
| Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression system. | Biotechnology and bioengineering 20100201 |
| Mechanistic insights into a Ca2+-dependent family of alpha-mannosidases in a human gut symbiont. | Nature chemical biology 20100201 |
| Calnexin phosphorylation attenuates the release of partially misfolded alpha1-antitrypsin to the secretory pathway. | The Journal of biological chemistry 20091211 |
| Novel mannosidase inhibitors probe glycoprotein degradation pathways in cells. | Glycoconjugate journal 20091201 |
| The production of glycoproteins by transient expression in Mammalian cells. | Methods in molecular biology (Clifton, N.J.) 20090101 |
| Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation. | Human molecular genetics 20080501 |
| Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function. | Biotechnology and bioengineering 20080215 |
| Defective protein folding and intracellular retention of thyroglobulin-R19K mutant as a cause of human congenital goiter. | Molecular endocrinology (Baltimore, Md.) 20080201 |
| Stimulation of ERAD of misfolded null Hong Kong alpha1-antitrypsin by Golgi alpha1,2-mannosidases. | Biochemical and biophysical research communications 20071026 |
| Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. | Journal of molecular biology 20070907 |
| Glycoprotein structural genomics: solving the glycosylation problem. | Structure (London, England : 1993) 20070301 |
| Detection of weak sugar binding activity of VIP36 using VIP36-streptavidin complex and membrane-based sugar chains. | Journal of biochemistry 20070201 |
| Man2C1, an alpha-mannosidase, is involved in the trimming of free oligosaccharides in the cytosol. | The Biochemical journal 20061115 |
| Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. | Glycobiology 20060801 |
| ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies. | Journal of cell science 20060615 |
| A practical synthesis of kifunensine analogues as inhibitors of endoplasmic reticulum alpha-mannosidase I. | The Journal of organic chemistry 20051125 |
| Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway. | The Journal of biological chemistry 20050513 |
| A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II. | Biochemistry 20050510 |
| Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms. | Biochemistry 20031202 |
| Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong alpha1-antitrypsin by human ER mannosidase I. | The Journal of biological chemistry 20030711 |
| N-linked oligosaccharide processing, but not association with calnexin/calreticulin is highly correlated with endoplasmic reticulum-associated degradation of antithrombin Glu313-deleted mutant. | Archives of biochemistry and biophysics 20030315 |
| Understanding protein structure-function relationships in Family 47 alpha-1,2-mannosidases through computational docking of ligands. | Proteins 20021001 |
| Structure of Penicillium citrinum alpha 1,2-mannosidase reveals the basis for differences in specificity of the endoplasmic reticulum and Golgi class I enzymes. | The Journal of biological chemistry 20020215 |
| N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL. | Journal of lipid research 20011001 |
| A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. | EMBO reports 20010515 |
| Glycoprotein quality control in the endoplasmic reticulum. Mannose trimming by endoplasmic reticulum mannosidase I times the proteasomal degradation of unassembled immunoglobulin subunits. | The Journal of biological chemistry 20010420 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.